3 Stock Overview
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Establishment Labs Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$34.00 |
| 52 Week High | US$63.50 |
| 52 Week Low | US$26.60 |
| Beta | 1.25 |
| 1 Month Change | 0% |
| 3 Month Change | 1.19% |
| 1 Year Change | -43.33% |
| 3 Year Change | -37.04% |
| 5 Year Change | 51.75% |
| Change since IPO | 65.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.003% | 1.8% |
| 1Y | -43.3% | -8.3% | 4.2% |
Return vs Industry: 3E0 underperformed the German Medical Equipment industry which returned -8.3% over the past year.
Return vs Market: 3E0 underperformed the German Market which returned 4.2% over the past year.
Price Volatility
| 3 volatility | |
|---|---|
| 3 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 3E0 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 3E0's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 908 | Juan Chacon Quiros | www.establishmentlabs.com |
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.
Establishment Labs Holdings Inc. Fundamentals Summary
| 3 fundamental statistics | |
|---|---|
| Market cap | €1.38b |
| Earnings (TTM) | -€73.09m |
| Revenue (TTM) | €153.76m |
9.0x
P/S Ratio-18.9x
P/E RatioIs 3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3 income statement (TTM) | |
|---|---|
| Revenue | US$165.15m |
| Cost of Revenue | US$58.17m |
| Gross Profit | US$106.98m |
| Other Expenses | US$185.48m |
| Earnings | -US$78.50m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | -2.86 |
| Gross Margin | 64.78% |
| Net Profit Margin | -47.53% |
| Debt/Equity Ratio | 1,026.0% |
How did 3 perform over the long term?
See historical performance and comparison